Radnet ( (RDNT) ) has released its Q1 earnings. Here is a breakdown of the information Radnet presented to its investors.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
RadNet, Inc. is a prominent provider of diagnostic imaging services in the United States, operating a network of outpatient imaging centers and offering radiology information technology and artificial intelligence solutions.
In the first quarter of 2025, RadNet reported a revenue increase of 9.2% to $471.4 million compared to the same period in 2024, despite challenges from Southern California wildfires and severe winter weather. The company also announced an upward revision of its 2025 financial guidance for revenue and adjusted EBITDA.
Key financial metrics revealed a mixed performance with total company adjusted EBITDA decreasing by 20.6% to $46.4 million, while the Digital Health segment saw a revenue increase of 31.1% to $19.2 million. Additionally, RadNet’s procedural volumes showed growth, particularly in advanced imaging, with PET/CT volume rising by nearly 23%. The company also announced a strategic acquisition of iCAD, Inc., aiming to enhance its AI-powered breast cancer detection capabilities.
Looking ahead, RadNet remains optimistic about its growth prospects, supported by strong procedural volumes and strategic initiatives. The company is confident in its ability to invest capital effectively and anticipates further advancements in its digital health and AI capabilities.